Xeltis has reported positive preliminary data for its Xabg coronary artery bypass conduit (CABG) in a trial that is underway at EU sites.

Saluda Medical has announced the full US commercial launch of its EVA sensing technology intended for scanning and analysing the spinal cord.

Medtronic has announced the first subject enrolment in the PELE trial, aiming to assess the Onyx liquid embolic system (LES).

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software.

BD has reached an agreement to merge its Biosciences & Diagnostic Solutions business with Waters Corporation in a nearly $17.5bn deal.

The medical device industry faces being pulled into a broader contest over control, sovereignty and industrial self-sufficiency.

FDA alerts users to issue with Olympus’s endoscope component after patient death Improper or incomplete reprocessing of the MAJ-891 forceps/irrigation plug has led to reports of patient infections.

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

Zimmer Biomet has signed a definitive agreement to acquire orthopaedic robotics company Monogram Technologies.

Researchers at the University of Queensland (UQ) have developed a new device to facilitate drug delivery into the brain safely.